Olliaro, P., Kuesel, A., Halleux, C., Sullivan, M., & Reeder, J. (2018). Creative use of the priority review voucher by public and not-for-profit actors delivers the first new FDA-approved treatment for river blindness in 20 years. Public Library of Science.
Чикаго-гийн эшлэл (17 дахь хэвлэлт)Olliaro, P., A. Kuesel, C. Halleux, M. Sullivan, ба J. Reeder. Creative Use of the Priority Review Voucher by Public and Not-for-profit Actors Delivers the First New FDA-approved Treatment for River Blindness in 20 Years. Public Library of Science, 2018.
MLA -ийн эшлэл (9 дэх хэвлэлт)Olliaro, P., et al. Creative Use of the Priority Review Voucher by Public and Not-for-profit Actors Delivers the First New FDA-approved Treatment for River Blindness in 20 Years. Public Library of Science, 2018.